BioSyent Declares Second Quarter 2023 Dividend

Article content material

MISSISSAUGA, Ontario, Could 25, 2023 (GLOBE NEWSWIRE) —  BioSyent Inc. (“BioSyent”, “the Firm”, TSX Enterprise: RX) is happy to announce that its Board of Administrators has declared a quarterly dividend of $0.04 per widespread share, payable in Canadian {Dollars} on June 15, 2023, to shareholders of file on the shut of enterprise on June 2, 2023. This second quarter 2023 dividend compares with the primary quarter 2023 dividend of $0.04 per widespread share. This dividend qualifies as an ‘eligible dividend’ for Canadian revenue tax functions. The declaration, timing, quantity and cost of future dividends stay on the discretion of the Board of Administrators.

Commercial 2

Article content material

About BioSyent Inc.

Article content material

Listed on the TSX Enterprise Change beneath the buying and selling image “RX”, BioSyent is a worthwhile growth-oriented specialty pharmaceutical firm centered on in-licensing or buying revolutionary pharmaceutical and different healthcare merchandise which were efficiently developed, are protected and efficient, and have a confirmed monitor file of enhancing the lives of sufferers. BioSyent helps the healthcare professionals that deal with these sufferers by advertising its merchandise via its group, specialty and worldwide enterprise items.

As of the date of this press launch, the Firm has 12,091,919 widespread shares excellent.

For a direct market quote for the TSX Enterprise Change and different Firm monetary data please go to

Commercial 3

Article content material

For additional data please contact:
Mr. René C. Goehrum
President and CEO
BioSyent Inc.
Telephone: 905-206-0013

This press launch might include data or statements which might be forward-looking. The contents herein signify our judgment, as on the launch date, and are topic to dangers and uncertainties that will trigger precise outcomes or outcomes to be materially totally different from the forward-looking data or statements. Potential dangers might embrace, however will not be restricted to, these related to scientific trials, product improvement, future income, operations, profitability and acquiring regulatory approvals.

Neither TSX Enterprise Change nor its Regulation Companies Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Change) accepts accountability for the adequacy or accuracy of this press launch.


Postmedia is dedicated to sustaining a full of life however civil discussion board for dialogue and encourage all readers to share their views on our articles. Feedback might take as much as an hour for moderation earlier than showing on the positioning. We ask you to maintain your feedback related and respectful. We’ve got enabled e mail notifications—you’ll now obtain an e mail in the event you obtain a reply to your remark, there may be an replace to a remark thread you comply with or if a consumer you comply with feedback. Go to our Neighborhood Tips for extra data and particulars on the way to alter your e mail settings.

Be part of the Dialog

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles